AzTrials
AzTrials

Cancer SurvivorsNCT06840028

Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors

A study testing mHealth/sFitRx and Fitness Tracker in people with Cancer Survivors and Chronic Disease, run by The University of Tennessee, Knoxville at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
mHealth/sFitRx and Fitness Tracker
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteUnited States
Study dates
1 Mar 2025to 15 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participant must be at least 18 years of age
  • Participant was previously diagnosed with stage 0-III cancer
  • Participant have had one or more of the cancers of interest (e.g., breast, lung)
  • Participant completed active cancer treatment at least three months prior to enrollment, with the exception of continued maintenance immunotherapy or endocrine therapy
  • Participant possess basic English communication capability
  • Participant do not participate in other health promotion programs
Show all 10Show fewer
  • Participant is an Android or Apple smartphone owner
  • Participant is willing to participate in mHealth-delivered programs
  • Participant is willing to consent and be randomized
  • Participant has no contraindications to PA participation

Who cannot join

  • Participant is currently undergoing chemotherapy or radiation as primary cancer treatment
  • Having any contraindications that might interfere with PA engagement, such as a medical condition and pacemaker implant
  • Plan to relocate or travel for >two weeks during the study period;
  • Presence of distant metastasis
  • Planning or preparing for surgery as primary treatment or as a reconstruction procedure in the next 3 months
  • Have a stage 4 cancer diagnosis
Show all 10Show fewer
  • Participant is already engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months
  • An unstable mental condition that would prevent following study protocols
  • Reporting a Physical Activity Readiness Questionnaire (PAR-Q) score that indicates PA may be unsafe
  • Being a prisoner, pregnant, or planning to become pregnant

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Tennessee Medical Center

    Knoxville, Tennessee, 37920

Other trials in United States

About this study

Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life.

As we live in an age of technology, health wearables and smartphone apps might be one novel manner by which to help cancer survivors increase physical activity as well as improve health outcomes. Yet, the effectiveness of wearable and app as a tool for health promotion among cancer survivors is largely unstudied.

The purpose of this study is to evaluate the effectiveness of a personalized m-health intervention via fitness wearable (Fitbit Inspire 3) exercise app (sFitRx) on physical activity, weight, quality of life, individual beliefs, and emotions among cancer survivors.

Read the detailed description

Cancer remains a vital public health concern in the U.S. Research has shown that physical activity (PA) provides many physical and mental health benefits after cancer diagnosis and plays an important role in reducing all-cause and cancer-related mortality, as well as cancer incidence, in cancer survivors (CS). Adopting a physically active lifestyle is therefore crucial to decrease cancer risk and improve cancer prognosis and quality of life. However, most CS do not achieve the recommended 150 min/week of moderate-to-vigorous PA (MVPA). This issue is particularly pronounced for CS in low-income, underserved areas who tend to have considerably less access to PA-conducive environments compared to their more affluent peers. It is therefore imperative to study innovative, ease-to-implement health interventions CS that can promote increased engagement and self-regulation of health behaviors, such as PA, while also improving other health outcomes; thereby offering better supportive care.

One promising easy-to-implement medium to improve engagement in and self-regulation of health behaviors is mobile health (mHealth), which includes advanced smartphone application technology often combined with wearables and social media to improve the healthcare delivery experience. Researchers have recently applied such technologies with CS to promote improved health through increased PA and reduced sedentary behavior (SB), with observations promising. Despite promising observations, these studies were often conducted with small samples over short durations (less than or equal to three months), with the interventions lacking personalized PA prescriptions informed by back end big data analysis techniques to further improve intervention implementation. As such, examining how a longer-term tailored, big data-informed mHealth PA intervention in CS might improve health and well-being would fill a major literature gap.

The investigators thus propose a 12-month randomized-controlled trial to investigate how an mHealth-delivered PA intervention informed by big data analysis (hereafter, 'personalized mHealth intervention') can improve the health and well-being of CS over a 12-month period. Experimental Group participants would receive access to a study-developed mHealth application, sFitRx, that delivers personalized PA programming as well as be provided with a fitness tracker to monitor their habitual PA levels. Comparison Group participants would receive the fitness tracker only. Successful study completion will inform the development of effective, mHealth-delivered PA programs in CS that might guide health professionals in the initiation of such novel programs in lower-income communities with the goal of promoting PA and health in this population.

Being tested
mHealth/sFitRx, Fitness Tracker
Keywords
U.S Cancer survivors, Tennessee Cancer Survivors, Cancer patient, Cancer, Chronic Disease, Physical Activity, Physical Inactivity, Rural oncology, Rural Health, Cancer outcomes, Cancer Recovery
Medical subject headings
Chronic Disease, Motor Activity, Sedentary Behavior, Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mHealth/sFitRxOther

    Experimental Group - Will receive a personalized mHealth application and fitness tracker. Specifically, Experimental Group participants will receive the sFitRx smartphone application that provides weekly personalized PA interventions informed by big data analysis. They will also receive a Fitbit Inspire 3 to track real-time PA, with PA data uploaded to Fitabase. Importantly, the PA data from the Fitbit Inspire 3 will inform the big data analyses used to generate the personalized PA intervention provided by the sFitRx application.

  • Fitness TrackerOther

    Comparison Group - Will receive the Fitbit Inspire 3 only.

Study groups in NCT06840028
Study groupRoleWhat they receive
Experimental GroupExperimentalExperimental Group participants would receive access to a study-developed mHealth application, sFitRx, that delivers personalized PA programming as well as be provided with a fitness tracker to monitor their habitual PA levels.
Receives: Other: mHealth/sFitRx
Comparison GroupActive comparatorComparison Group participants would receive the fitness tracker only.
Receives: Other: Fitness Tracker

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical Activity

    Physical Activity. CS's mean steps/day will be the primary outcome and will be assessed using Fitbit Inspire. Participants will be instructed to wear the Fitbit on the non-dominant wrist at all times throughout the study.

    Measured: Baseline (i.e., pre-intervention), six months, and 12 months.

Secondary outcomes (5)
  1. Health Indicators

    Participants' height (m) and weight (kg) will be measured at home by themselves, with body mass index (BMI) calculated by their height and weight (kg/m^2).43

    Measured: Baseline (i.e., pre-intervention), six months, and 12 months.

  2. Health Indicators

    Psychosocial beliefs (e.g., self-efficacy, social support) will be assessed by standardized self-report surveys through established questionnaires.45-50

    Measured: Baseline (i.e., pre-intervention), six months, and 12 months.

  3. Health Indicators

    The investigators will assess quality of life (QoL) using the Patient Reported Outcome Measurement Information System44. Investigators are most interested in assessing physical functioning, anxiety, and depression.

    Measured: Baseline (i.e., pre-intervention), six months, and 12 months.

  4. Physical Activity

    Mean calories burned/day and SB/day will also be examined as a secondary outcome. As mentioned previously, investigators will retrieve Fitbit data via Fitabase.40-42

    Measured: Baseline (i.e., pre-intervention), six months, and 12 months.

  5. Health Indicators

    The researchers will assess participants emotions via the Positive and Negative Affect Scale.

    Measured: Baseline (i.e., pre-intervention), six months, and 12 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2025
  2. Study start1 Mar 2025
  3. Primary completion15 Apr 2027 (estimated)
  4. Study completion15 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06840028
Sponsor's protocol ID
UTK IRB-24-07955-XP
Status last verified
Apr 2026
First submitted
5 Feb 2025
Last updated
1 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing mHealth/sFitRx and Fitness Tracker in people with Cancer Survivors and Chronic Disease, run by The University of Tennessee, Knoxville at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical Activity (time frame: Baseline (i.e., pre-intervention), six months, and 12 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in